| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.54 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.54 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.54 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.54 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
0.54 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.54 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.54 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.54 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.54 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.54 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.54 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
0.54 |
Evidence |
|
| CENTB1 |
CENTB1, KIAA0050: Centaurin-beta 1 |
CHC1 |
RCC1: RCC1-I (Fragment) |
0.54 |
Evidence |
|
| AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
DSG2 |
DSG2: Desmoglein-2 precursor |
0.54 |
Evidence |
|
| VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
DSG2 |
DSG2: Desmoglein-2 precursor |
0.54 |
Evidence |
|
| CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
AVPR1B |
AVPR1B, AVPR3, VPR3: Vasopressin V1b receptor |
0.54 |
Evidence |
|
| MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.54 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.54 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.54 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.54 |
Evidence |
|
| AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.54 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.54 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
0.54 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.54 |
Evidence |
|
| PROZ |
PROZ: Vitamin K-dependent protein Z precursor |
CDO1 |
CDO1: Cysteine dioxygenase type 1 |
0.54 |
Evidence |
|